Increased humoral responses to PDIA3 were also observed in patients across a diverse array of chronic inflammatory liver conditions, such as autoimmune hepatitis, primary biliary cholangitis, and T2D, further supporting PDIA3 as an important liver-derived autoantigen during liver inflammation. Here, PDIA3 is linked to type 2 diabetes mellitus.